U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H15ClN2
Molecular Weight 270.757
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MEDAZEPAM

SMILES

CN1CCN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3

InChI

InChIKey=YLCXGBZIZBEVPZ-UHFFFAOYSA-N
InChI=1S/C16H15ClN2/c1-19-10-9-18-16(12-5-3-2-4-6-12)14-11-13(17)7-8-15(14)19/h2-8,11H,9-10H2,1H3

HIDE SMILES / InChI
Medazepam is a benzodiazepine drug with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is known by the following brand names: Azepamid, Nobrium, Tranquirax (mixed with bevonium), Rudotel, Raporan, Ansilan and Mezapam. Marketed in Russia. Indicated for the treatment of neurotic disorders and states, accompanied with sense of fear, anxiety, intension, raised irritability, insomnia, vegetative lability.

Originator

Curator's Comment: # F. Hoffmann-La Roche Co., Ltd.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Nobrium

Approved Use

This medication is used in the treatment of anxiety disorders, alcohol withdrawal, tremor, muscle spasms and to control seizures. It may also be used before surgery or procedures to reduce apprehension and anxiety.
Primary
Nobrium

Approved Use

This medication is used in the treatment of anxiety disorders, alcohol withdrawal, tremor, muscle spasms and to control seizures. It may also be used before surgery or procedures to reduce apprehension and anxiety.
Primary
Nobrium

Approved Use

This medication is used in the treatment of anxiety disorders, alcohol withdrawal, tremor, muscle spasms and to control seizures. It may also be used before surgery or procedures to reduce apprehension and anxiety.
PubMed

PubMed

TitleDatePubMed
Medazepam compared with amylobarbitone in treatment of anxiety.
1971 Jan 16
Bromazepam, medazepam, chlordiazepoxide in treatment of neurotic anxiety.
1974 May
[Analysis of benzodiazepine derivative mixture by gas-liquid chromatography].
2002
Substrate specificity of human 3(20)alpha-hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines.
2002 Apr
A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy.
2002 Mar 10
Direct injection micellar liquid chromatographic determination of benzodiazepines in serum.
2002 Nov 25
[Determination of diazepine derivatives: alprazolam, medazepam, chlordiazepoxid mixture by high performance liquid chromatography].
2003
Selective and potent inhibitors of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone.
2003 Feb 1
Determination of clofazimine in leprosy patients by high-performance liquid chromatography.
2003 Sep
Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization.
2004 Aug
Determination of diazepam in cream biscuits by liquid chromatography.
2004 May-Jun
The educational background and qualifications of UK medical students from ethnic minorities.
2008 Apr 16
Adverse drug effects in hospitalized elderly: data from the healthcare cost and utilization project.
2010
Development and validation of an EI-GC-MS method for the determination of benzodiazepine drugs and their metabolites in blood: applications in clinical and forensic toxicology.
2010 Aug 1
Evaluation of an hPXR reporter gene assay for the detection of aquatic emerging pollutants: screening of chemicals and application to water samples.
2010 Jan
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime.
2010 Jan 4
Barriers to treatment adherence in physiotherapy outpatient clinics: a systematic review.
2010 Jun
Benzodiazepines medazepam and midazolam are activators of pregnane X receptor and weak inducers of CYP3A4: investigation in primary cultures of human hepatocytes and hepatocarcinoma cell lines.
2010 Mar 15
Effectiveness of additional supervised exercises compared with conventional treatment alone in patients with acute lateral ankle sprains: systematic review.
2010 Oct 26
Patents

Sample Use Guides

In Vivo Use Guide
The average dose for adults: single - 10-20 mg, the average daily - 20-30 mg, the maximum - 60-70 mg / day. At the beginning of treatment - for 5 mg 2-3 times a day, then gradually increase the dose to 30-40 mg per day. In outpatient settings recommended by 5 mg in the morning and in the afternoon, and 10 mg in the evening. Elderly patients, teenagers, as well as kidney function - 5-10 mg 1-2 times a day, or 10 mg at night. Babies dose depends on the age and body weight. Treatment duration should be as short as possible (about 2 Sun) and should not exceed 2 Months (including the period of gradual reduction of the dose).
Route of Administration: Oral
In Vitro Use Guide
Medazepam (10 (-5) M) inhibited the contractile response of circular muscle strips from the isolated guinea-pig gallbladder to sulfated cholecystokinin octapeptide (CCK8) in the presence of atropine.
Name Type Language
MEDAZEPAM
INN   MART.   MI   WHO-DD  
INN  
Official Name English
medazepam [INN]
Common Name English
MEDAZEPAM [MI]
Common Name English
Medazepam [WHO-DD]
Common Name English
MEDAZEPAM [JAN]
Common Name English
MEDAZEPAM [MART.]
Common Name English
PAMNACE
Brand Name English
Classification Tree Code System Code
NCI_THESAURUS C1012
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
WHO-VATC QN05BA03
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
WHO-ATC N05BA03
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
DEA NO. 2836
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
Code System Code Type Description
EVMPD
SUB08689MIG
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY
MESH
D008472
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY
MERCK INDEX
m7127
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY Merck Index
ECHA (EC/EINECS)
220-783-4
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY
FDA UNII
P0J3387W3S
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY
WIKIPEDIA
MEDAZEPAM
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY
PUBCHEM
4041
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY
ChEMBL
CHEMBL28333
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY
NCI_THESAURUS
C66068
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY
INN
2517
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY
CAS
2898-12-6
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY
EPA CompTox
DTXSID1048708
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY
SMS_ID
100000081988
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY
DRUG BANK
DB13437
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY
RXCUI
6680
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY RxNorm
DRUG CENTRAL
1654
Created by admin on Sat Dec 16 16:43:40 GMT 2023 , Edited by admin on Sat Dec 16 16:43:40 GMT 2023
PRIMARY